🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 8 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/04/2018 | 100,57 | 102,28 | 97,64 | 98,49 | -1,69% | 4,62% | 298.158 |
| 04/04/2018 | 97,60 | 100,46 | 97,51 | 100,18 | +1,13% | 3,02% | 362.759 |
| 03/04/2018 | 100,22 | 101,23 | 96,71 | 99,06 | -0,86% | 4,51% | 492.602 |
| 02/04/2018 | 102,65 | 102,99 | 98,68 | 99,91 | -3,03% | 4,20% | 431.367 |
| 29/03/2018 | 101,45 | 104,52 | 100,73 | 103,03 | +1,94% | 3,73% | 335.829 |
| 28/03/2018 | 101,98 | 101,98 | 98,58 | 101,07 | -0,75% | 3,34% | 419.505 |
| 27/03/2018 | 105,65 | 106,28 | 101,05 | 101,83 | -3,35% | 4,95% | 579.805 |
| 26/03/2018 | 102,15 | 105,63 | 100,75 | 105,35 | +4,72% | 4,78% | 443.871 |
| 23/03/2018 | 100,82 | 103,21 | 100,44 | 100,61 | -0,37% | 2,74% | 386.483 |
| 22/03/2018 | 103,68 | 103,99 | 100,75 | 100,98 | -3,04% | 3,13% | 546.142 |
| 21/03/2018 | 104,49 | 105,51 | 103,68 | 104,14 | -0,47% | 1,76% | 337.592 |
| 20/03/2018 | 105,47 | 105,68 | 104,26 | 104,64 | -0,39% | 1,35% | 482.824 |
| 19/03/2018 | 106,36 | 106,90 | 102,94 | 105,05 | -2,01% | 3,72% | 939.518 |
| 16/03/2018 | 110,88 | 111,62 | 105,60 | 107,21 | -3,41% | 5,43% | 1.870.541 |
| 15/03/2018 | 112,41 | 112,45 | 110,67 | 110,99 | -0,66% | 1,58% | 333.424 |
| 14/03/2018 | 111,82 | 113,51 | 110,12 | 111,73 | +0,56% | 3,03% | 689.290 |
| 13/03/2018 | 114,16 | 115,28 | 110,79 | 111,10 | -2,48% | 3,93% | 596.957 |
| 12/03/2018 | 111,70 | 114,42 | 110,42 | 113,92 | +3,74% | 3,59% | 785.149 |
| 09/03/2018 | 109,96 | 110,90 | 109,02 | 109,82 | +0,77% | 1,71% | 562.172 |
| 08/03/2018 | 105,17 | 109,64 | 105,17 | 108,98 | +3,95% | 4,25% | 923.969 |
| 07/03/2018 | 103,64 | 105,58 | 101,67 | 104,84 | +1,32% | 3,77% | 725.999 |
| 06/03/2018 | 102,00 | 103,64 | 100,87 | 103,47 | +2,11% | 2,71% | 599.522 |
| 05/03/2018 | 99,10 | 102,47 | 98,58 | 101,34 | +2,16% | 3,92% | 486.350 |
| 02/03/2018 | 96,18 | 99,73 | 95,49 | 99,20 | +2,89% | 4,41% | 620.842 |
| 01/03/2018 | 94,81 | 96,64 | 93,94 | 96,41 | +1,74% | 2,84% | 588.782 |
| 28/02/2018 | 94,57 | 96,33 | 94,33 | 94,75 | +0,32% | 2,11% | 418.864 |
| 27/02/2018 | 94,33 | 95,71 | 94,33 | 94,45 | -0,80% | 1,47% | 496.930 |
| 26/02/2018 | 96,38 | 96,98 | 94,83 | 95,21 | -0,77% | 2,23% | 337.271 |
| 23/02/2018 | 96,69 | 97,00 | 94,39 | 95,95 | -1,11% | 2,70% | 451.084 |
| 22/02/2018 | 96,38 | 98,69 | 95,27 | 97,02 | -0,52% | 3,55% | 332.943 |